← Back

Streptomycin

Anti-Infective Medicines
Powder · Injection1 g6 brands · 4 makers
Streptomycin is listed in Nepal's National List of Essential Medicines (NLEM, Sixth Revision 2021) under Anti-Infective Medicines. 6 brand names for this medicine are listed in the NepalDoc medicine catalog.
Generic namestreptomycin
Therapeutic classAnti-Infective Medicines > 6.2.5 Antituberculosis medicines (complementary list)
Form & strength (NLEM)Powder for injection: 1 g (as sulfate) in vial
Source / स्रोतNational List of Essential Medicines Nepal (2021); NepalDoc medicine catalog

What it's for

Streptomycin is indicated for the treatment of individuals with moderate to severe infections caused by susceptibile strains of microorganisms in the specific conditions listed below: 1.

From the U.S. FDA-approved label for Streptomycin. Full label: DailyMed.

Streptomycin is indicated for the treatment of individuals with moderate to severe infections caused by susceptibile strains of microorganisms in the specific conditions listed below: 1. Mycobacterium tuberculosis: The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Center for Disease Control recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH or rifampin resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. In the past when the national rate of primary drug resistance to isoniazid was known to be less than 4% and was either stable or declining, therapy with two and three drug regimens was considered adequate. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered. Streptomycin is also indicated for therapy of tuberculosis when one or more of the above drugs is contraindicated because of toxicity or intolerance.

From the U.S. FDA-approved label for Streptomycin. Full label: DailyMed.

Intramuscular Route Only Adults: The preferred site is the upper outer quadrant of the buttock (i.e., gluteus maximus) or the mid-lateral thigh. Children: It is recommended that intramuscular injections be given preferably in the mid-lateral muscles of the thigh. In infants and small children the periphery of the upper outer quadrant of the gluteal region should be used only when necessary, such as in burn patients, in order to minimize the possibility of damage to the sciatic nerve.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

A history of clinically significant hypersensitivity to streptomycin is a contraindication to its use. Clinically significant hypersensitivity to other aminoglycosides may contraindicate the use of streptomycin because of the known cross-sensitivity of patients to drugs in this class.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Ototoxicity Both vestibular and auditory dysfunction can follow the administration of streptomycin. The degree of impairment is directly proportional to the dose and duration of streptomycin administration, to the age of the patient, to the level of renal function and to the amount of underlying existing auditory dysfunction. The ototoxic effects of the aminoglycosides, including streptomycin, are potentiated by the co-administration of ethacrynic acid, mannitol, furosemide and possibly other diuretics. The vestibulotoxic potential of streptomycin exceeds that of its capacity for cochlear toxicity.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following reactions are common: vestibular ototoxicity (nausea, vomiting, and vertigo); paresthesia of face; rash; fever; urticaria; angioneurotic edema; and eosinophilia. The following reactions are less frequent: cochlear ototoxicity (deafness); exfoliative dermatitis; anaphylaxis; azotemia; leucopenia; thrombocytopenia; pancytopenia; hemolytic anemia; muscular weakness; and amblyopia.

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

6 products from 4 makers in the NepalDoc medicine catalog use this generic:

BrandCompositionMakerPack
Strep 1 1gm InjectionStreptomycin (1gm)Shiv Pharmaceutical Laboratories
Strep 750 750mg InjectionStreptomycin (750mg)Shiv Pharmaceutical Laboratories
Ambistryn-S 0.75gm InjectionStreptomycin (0.75gm)Abbottvial of 1 Powder for Injection
Ambistryn-S 1gm InjectionStreptomycin (1gm)Abbottvial of 1 Injection
Genpod 200mg TabletStreptomycin (200mg)Genecia Healthcarestrip of 10 tablets
MERSTREP 1GM INJECTIONStreptomycin (1gm)Wockhardt Ltdvial of 1 Injection

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Store dry powder at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT Manufactured for: XGen Pharmaceuticals DJB, Inc.

Storage information from the U.S. FDA-approved label.

Search medicines in the app / एपमा औषधि खोज्नुहोस् Find a pharmacy / फार्मेसी खोज्नुहोस्
+ Safety information

This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.

NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.